$IART Cashflow Statement | Understand Stock

$IART

$12.83 +$0.59 (4.82%) Close

$IART Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES:
Net (loss) income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Non-cash in-process research and development expense
Non-cash impairment charges
Deferred income tax benefit
Share-based compensation
Amortization of debt issuance costs and expenses associated with debt refinancing
Non-cash lease expense
Accretion of bond issuance discount
Lease incentive
Loss on disposal of property and equipment and construction in-progress
Gain from the sale of businesses
Change in fair value of contingent consideration and others
Changes in assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other non-current assets
Accounts payable, accrued expenses and other current liabilities
Contract liabilities
Other non-current liabilities

Net cash provided by operating activities
INVESTING ACTIVITIES:
Purchases of property and equipment
Purchases of intangible assets
Proceeds from sale of business
Acquired in-process research and development and intangibles
Proceeds from note receivable
Purchases of short-term investments
Proceeds from maturities of short-term investments
Cash paid for business acquisitions, net of cash acquired
Proceeds from sales of property and equipment
Net (payment) proceeds on swaps designated as net investment hedges
Net cash used in investing activities

FINANCING ACTIVITIES:
Proceeds from borrowings of long-term indebtedness
Payments on debt
Purchase of option hedge on convertible notes
Proceeds from convertible notes issuance
Proceeds from sale of stock purchase warrants
Repayments of convertible debt
Payment of debt issuance costs
Purchase of treasury stock
Payments for contingent considerations
Proceeds from exercise of stock options and employee stock purchase plan
Cash taxes paid in net equity settlement
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments